Market Closed -
Bombay S.E.
06:00:50 2024-05-03 am EDT
|
5-day change
|
1st Jan Change
|
203.2
INR
|
-0.22%
|
|
0.00%
|
-9.79%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,309
|
924.5
|
640.5
|
2,723
|
13,790
|
5,637
|
Enterprise Value (EV)
1 |
1,526
|
914.5
|
672.9
|
3,298
|
15,515
|
6,866
|
P/E ratio
|
6.95
x
|
7.56
x
|
1.72
x
|
4.35
x
|
14.1
x
|
13
x
|
Yield
|
0.94%
|
1.33%
|
3.84%
|
1.35%
|
0.45%
|
0.65%
|
Capitalization / Revenue
|
0.52
x
|
0.35
x
|
0.23
x
|
0.9
x
|
2.82
x
|
0.78
x
|
EV / Revenue
|
0.61
x
|
0.34
x
|
0.24
x
|
1.09
x
|
3.17
x
|
0.95
x
|
EV / EBITDA
|
7.46
x
|
6.7
x
|
1.6
x
|
5.03
x
|
13
x
|
8.41
x
|
EV / FCF
|
13.2
x
|
3.41
x
|
-3.08
x
|
-5.26
x
|
-13.2
x
|
9.02
x
|
FCF Yield
|
7.57%
|
29.3%
|
-32.5%
|
-19%
|
-7.56%
|
11.1%
|
Price to Book
|
0.35
x
|
0.2
x
|
0.16
x
|
0.52
x
|
1.51
x
|
0.72
x
|
Nbr of stocks (in thousands)
|
24,588
|
24,588
|
24,588
|
24,588
|
24,588
|
24,588
|
Reference price
2 |
53.25
|
37.60
|
26.05
|
110.8
|
560.8
|
229.2
|
Announcement Date
|
8/27/18
|
8/28/19
|
9/4/20
|
9/1/21
|
7/27/22
|
8/29/23
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,520
|
2,657
|
2,772
|
3,035
|
4,889
|
7,232
|
EBITDA
1 |
204.7
|
136.4
|
421.7
|
656.1
|
1,193
|
816.8
|
EBIT
1 |
61.18
|
114.8
|
399.6
|
637.4
|
1,129
|
494.4
|
Operating Margin
|
2.43%
|
4.32%
|
14.41%
|
21%
|
23.09%
|
6.84%
|
Earnings before Tax (EBT)
1 |
172.4
|
160.4
|
489.2
|
797.1
|
1,264
|
541.7
|
Net income
1 |
151.7
|
122.3
|
372.8
|
626.1
|
977.1
|
432
|
Net margin
|
6.02%
|
4.6%
|
13.44%
|
20.63%
|
19.98%
|
5.97%
|
EPS
2 |
7.657
|
4.973
|
15.16
|
25.47
|
39.74
|
17.57
|
Free Cash Flow
1 |
115.6
|
268.2
|
-218.6
|
-626.6
|
-1,172
|
761.6
|
FCF margin
|
4.59%
|
10.09%
|
-7.88%
|
-20.65%
|
-23.98%
|
10.53%
|
FCF Conversion (EBITDA)
|
56.45%
|
196.59%
|
-
|
-
|
-
|
93.25%
|
FCF Conversion (Net income)
|
76.16%
|
219.34%
|
-
|
-
|
-
|
176.3%
|
Dividend per Share
2 |
0.5000
|
0.5000
|
1.000
|
1.500
|
2.500
|
1.500
|
Announcement Date
|
8/27/18
|
8/28/19
|
9/4/20
|
9/1/21
|
7/27/22
|
8/29/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
217
|
-
|
32.4
|
575
|
1,725
|
1,230
|
Net Cash position
1 |
-
|
9.97
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.059
x
|
-
|
0.0767
x
|
0.8757
x
|
1.446
x
|
1.505
x
|
Free Cash Flow
1 |
116
|
268
|
-219
|
-627
|
-1,172
|
762
|
ROE (net income / shareholders' equity)
|
3.88%
|
2.68%
|
8.79%
|
13.7%
|
13.6%
|
5.11%
|
ROA (Net income/ Total Assets)
|
0.9%
|
1.5%
|
5.73%
|
7.54%
|
7.85%
|
2.91%
|
Assets
1 |
16,881
|
8,135
|
6,508
|
8,309
|
12,443
|
14,843
|
Book Value Per Share
2 |
153.0
|
186.0
|
159.0
|
214.0
|
371.0
|
317.0
|
Cash Flow per Share
2 |
0.1700
|
0.4100
|
0.1400
|
0.3800
|
0.2500
|
0.0300
|
Capex
1 |
9.59
|
8.48
|
212
|
1,522
|
1,010
|
76.6
|
Capex / Sales
|
0.38%
|
0.32%
|
7.63%
|
50.15%
|
20.66%
|
1.06%
|
Announcement Date
|
8/27/18
|
8/28/19
|
9/4/20
|
9/1/21
|
7/27/22
|
8/29/23
|
|
1st Jan change
|
Capi.
|
---|
| -9.79% | 59.93M | | +14.70% | 65.04B | | -1.61% | 47.76B | | +14.58% | 40.72B | | +20.84% | 26.88B | | +9.54% | 19.29B | | +1.16% | 17.53B | | -21.87% | 16.03B | | +1.11% | 15.17B | | -11.34% | 15.06B |
Other Specialty Chemicals
|